MCID: SPN021
MIFTS: 40

Spinal Meningioma

Categories: Cancer diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Spinal Meningioma

MalaCards integrated aliases for Spinal Meningioma:

Name: Spinal Meningioma 12 53 15 72
Meningioma 44 72
Meningioma, Benign, No Icd-O Subtype 72
Spinal Cord Meningioma 12
Meningioma, Spine 53

Classifications:



External Ids:

Disease Ontology 12 DOID:1138
MeSH 44 D008579
NCIt 50 C6935
UMLS 72 C0025286 C0347515 C1762616

Summaries for Spinal Meningioma

NIH Rare Diseases : 53 Spinal meningioma is a rare type of spinal cord cancer. The spinal cord is part of the central nervous system. This tumor often affects middle-aged women. Tumors of the spinal cord can be either primary or arise from other primary tumors (metastatic), and are typically slow growing. The initial signs and symptoms include headache and recent onset of seizures. Other features are motor deficits, sensory deficits, pain, and sphincter dysfunction. The thoracic spine (middle back) is the most common site, followed by the cervical spine (neck). These tumors are rarely seen in the lumbar region (lower back). The only proven risk factor in the development of meningioma is exposure to ionizing radiation. Also, patients with neurofibromatosis type 2 are at increased risk of developing meningioma. Surgery is the treatment of choice and complete tumor removal is reached in the vast majority of patients. The prognosis after surgical resection is excellent.

MalaCards based summary : Spinal Meningioma, also known as meningioma, is related to benign meningioma and spinal canal and spinal cord meningioma. An important gene associated with Spinal Meningioma is NF2 (Neurofibromin 2). The drugs Thrombin and Hemostatics have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and bone.

Related Diseases for Spinal Meningioma

Diseases related to Spinal Meningioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1053)
# Related Disease Score Top Affiliating Genes
1 benign meningioma 33.3 SMARCE1 NF2
2 spinal canal and spinal cord meningioma 31.1 SMARCE1 NF2 MIB1 FAT2
3 meningioma, familial 30.7 SMARCE1 NF2
4 meningothelial meningioma 30.2 SMARCE1 NF2
5 neuroma 29.9 NF2 LZTR1
6 neurilemmomatosis 28.8 SMARCE1 NF2 LZTR1
7 optic nerve sheath meningioma 12.5
8 intraorbital meningioma 12.4
9 rhabdoid meningioma 12.4
10 childhood brain meningioma 12.3
11 lung meningioma 12.3
12 chordoid meningioma 12.3
13 cavernous sinus meningioma 12.3
14 cerebral meningioma 12.3
15 skull base meningioma 12.3
16 clear cell meningioma 12.3
17 tuberculum sellae meningioma 12.3
18 olfactory groove meningioma 12.3
19 foramen magnum meningioma 12.2
20 angiomatous meningioma 12.2
21 cerebellopontine angle meningioma 12.2
22 parasagittal meningioma 12.2
23 clivus meningioma 12.2
24 pineal region meningioma 12.2
25 petrous apex meningioma 12.2
26 petroclival meningioma 12.2
27 anterior cranial fossa meningioma 12.2
28 intraventricular meningioma 12.2
29 choroid plexus meningioma 12.2
30 cerebral falx meningioma 12.2
31 lower clivus meningioma 12.2
32 suprasellar meningioma 12.2
33 jugular foramen meningioma 12.2
34 pediatric meningioma 12.2
35 lateral ventricle meningioma 12.2
36 sphenoorbital meningioma 12.2
37 internal auditory canal meningioma 12.2
38 diaphragma sellae meningioma 12.2
39 middle cranial fossa meningioma 12.2
40 frontal convexity meningioma 12.2
41 parapharyngeal meningioma 12.2
42 bilateral meningioma of optic nerve 12.2
43 pituitary stalk meningioma 12.2
44 brainstem intraparenchymal clear cell meningioma 12.2
45 anterior foramen magnum meningioma 12.2
46 anterior optic tract meningioma 12.2
47 intracerebral cystic meningioma 12.2
48 skin meningioma 12.2
49 multiple skull base meningioma 12.1
50 cerebral convexity meningioma 12.1

Graphical network of the top 20 diseases related to Spinal Meningioma:



Diseases related to Spinal Meningioma

Symptoms & Phenotypes for Spinal Meningioma

Drugs & Therapeutics for Spinal Meningioma

Drugs for Spinal Meningioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 258)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Thrombin Approved, Investigational Phase 4
2 Hemostatics Phase 4
3 Coagulants Phase 4
4 Fibrin Tissue Adhesive Phase 4
5
Tranexamic Acid Approved Phase 3 1197-18-8 5526
6
Progesterone Approved, Vet_approved Phase 3 57-83-0 5994
7
Donepezil Approved Phase 3 120014-06-4 3152
8
Cisplatin Approved Phase 3 15663-27-1 84093 441203 2767
9
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
10
Ondansetron Approved Phase 3 99614-02-5 4595
11
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
12
Cisatracurium Approved Phase 3 96946-41-7
13
Sevoflurane Approved, Vet_approved Phase 3 28523-86-6 5206
14
Propofol Approved, Investigational, Vet_approved Phase 3 2078-54-8 4943
15
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 3 7487-88-9 24083
16
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
17
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
18
Histamine Approved, Investigational Phase 3 51-45-6 774
19
Cyproheptadine Approved Phase 3 129-03-3 2913
20
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
21 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
22 Antifibrinolytic Agents Phase 3
23 Progestins Phase 3
24 Peripheral Nervous System Agents Phase 3
25 Cholinesterase Inhibitors Phase 3
26 Cholinergic Agents Phase 3
27 Nootropic Agents Phase 3
28 Liver Extracts Phase 3
29 Emetics Phase 3
30 Cola Phase 3
31 Anesthetics, Intravenous Phase 3
32 Narcotics Phase 3
33 Analgesics, Opioid Phase 3
34 Adjuvants, Anesthesia Phase 3
35 Anesthetics, General Phase 3
36 Analgesics Phase 3
37 Tocolytic Agents Phase 3
38 Central Nervous System Depressants Phase 3
39 Antihypertensive Agents Phase 3
40 Anesthetics Phase 3
41 Anti-Arrhythmia Agents Phase 3
42 Anticonvulsants Phase 3
43 Vasoconstrictor Agents Phase 3
44 calcium channel blockers Phase 3
45 Calcium, Dietary Phase 3
46 Gastrointestinal Agents Phase 3
47 Central Nervous System Stimulants Phase 3
48 Neurotransmitter Agents Phase 3
49 Dermatologic Agents Phase 3
50 Dexmethylphenidate Hydrochloride Phase 3

Interventional clinical trials:

(show top 50) (show all 189)
# Name Status NCT ID Phase Drugs
1 Neurocognitive Outcome Assessment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial. Unknown status NCT03190122 Phase 4
2 Dissection of the Outer Layer of the Lateral Wall of the Cavernous Sinus Decreases Bleeding as Compared to Direct Tumor Attack in Middle Fossa Meningiomas: A Randomized Controlled Trial Unknown status NCT02863484 Phase 4
3 A Prospective, Randomized, Controlled Phase IV Study to Compare Bioseal Versus Standard of Care as an Adjunct to Hemostasis in Elective Brain Tumor Surgery Completed NCT02034799 Phase 4
4 PHASE 3 STUDY OF EFFICACY OF TRANEXAMIC ACID IN BRAIN TUMORS RESECTIONS Unknown status NCT01655927 Phase 3 Tranexamic Acid;Placebo: Saline
5 Efficacy of Stereotactic Conformal Radiotherapy (SCRT) Compared to Conventional Radiotherapy in Minimising Late Sequelae in Children and Young Adults With Brain Tumours: a Randomised Clinical Trial Unknown status NCT00517959 Phase 3
6 Double Blind Randomized Trial of the Anti-Progestational Agent Mifepristone In The Treatment of Unresectable Meningioma Completed NCT03015701 Phase 3 Mifepristone
7 Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
8 Prospective Study Of Patients With Recurrent Or Incomplete Excised Benign Intercranial Meningiomas For The Evaluation Of Treatment Result With Combined Proton And Photon Irradiation To Doses 55.8 Or 63.0 CGE Completed NCT02947984 Phase 3
9 Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
10 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
11 Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma Recruiting NCT03180268 Phase 3
12 The Effect of Magnesium Sulphate on Intraoperative Blood Loss in Meningioma Patient Undergoing Craniotomy With Tumor Removal Not yet recruiting NCT03558516 Phase 3 Magnesium group;Normal saline group
13 Observation Versus Conventional-Fractionated Radiotherapy or Radiosurgery After Non-radical Surgery for Benign Intracranial Meningiomas: A Phase III Study Terminated NCT00104936 Phase 3
14 A Phase III, Double-Blind, Prospective Randomized Clinical Trial of the Effect of D-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy Terminated NCT00031798 Phase 3 methylphenidate hydrochloride
15 Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
16 Phase II Study of Hydroxyurea for the Treatment of Recurrent and/or Nonoperable Meningioma Unknown status NCT00006119 Phase 2 hydroxyurea
17 IMATINIB Plus Hydroxyurea in the Treatment of Recurrent or Progressive Meningiomas: a Randomized Phase II Study Unknown status NCT00904735 Phase 2 hydroxyurea;imatinib mesylate
18 Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas. Unknown status NCT02333565 Phase 2 Everolimus;Octreotide
19 Feasibility and Phase II Study Using Proton Radiation For WHO Grade I-III Meningiomas and Hemangiopericytomas Unknown status NCT01117844 Phase 1, Phase 2
20 Proton Radiation for Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
21 Trabectedin for Recurrent Grade II or III Meningioma: a Randomized Phase II Study of the EORTC Brain Tumor Group Completed NCT02234050 Phase 2 Trabectedin
22 Phase II Study of Hydroxyurea for Unresectable Meningioma Completed NCT00003590 Phase 2 hydroxyurea
23 A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas Completed NCT00348790 Phase 2 vatalanib
24 Adjuvant Postoperative High-Dose Radiotherapy for Atypical and Malignant Meningioma: a Phase-II and Observation Study Completed NCT00626730 Phase 2
25 Phase II Study of Monthly SOM230C for Recurrent or Progressive Meningioma Completed NCT00859040 Phase 2 SOM230C
26 A Phase II Study of Imatinib Mesylate Plus Hydroxyurea in the Treatment of Patients With Recurrent/Progressive Meningioma Completed NCT00354913 Phase 2 hydroxyurea;imatinib mesylate
27 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Completed NCT00589784 Phase 2 Sunitinib
28 Phase II Trial of STI571 (NSC 716051) in Patients With Recurrent Meningioma Completed NCT00045734 Phase 2 imatinib mesylate
29 A Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue Completed NCT01032200 Phase 2 Armodafinil
30 Phase I/II Trial of STI571 (NSC 716051) in Patients With Recurrent Malignant Gliomas Completed NCT00010049 Phase 1, Phase 2 imatinib mesylate
31 Levetiracetam and Pregabalin for Monotherapy in Patients With Brain Tumors and Seizures. A Phase II Randomized Study. Completed NCT00629889 Phase 2 levetiracetam;pregabalin
32 A Phase I/II Trial of OSI-774 in Patients With Recurrent Malignant Gliomas and Malignant Gliomas Post Radiation Therapy Completed NCT00045110 Phase 1, Phase 2 erlotinib hydrochloride
33 A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors Completed NCT00006102 Phase 2 becatecarin
34 Phase II Treatment of Children With Newly Diagnosed Malignant Central Nervous System Tumors With Temozolomide Prior to Radiation Therapy Completed NCT00005955 Phase 2 temozolomide
35 A Randomized Phase II Trial of Bevacizumab to Control Brain Radiation Damage Completed NCT00492089 Phase 2 bevacizumab;placebo
36 A Phase I/II Trial of SU5416 in Patients With Recurrent High Grade Astrocytomas or Mixed Gliomas Completed NCT00004868 Phase 1, Phase 2 semaxanib
37 Phase I Study of At-Labeled Anti-Tenascin Human/Mouse Chimeric Monoclonal Antibody 81C6 (ch81C6) Via Surgically Created Cystic Resection Cavity in the Treatment of Patients With Primary or Metastatic Brain Tumors Completed NCT00003461 Phase 1, Phase 2
38 Donepezil and EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases Completed NCT00070161 Phase 2 donepezil hydrochloride
39 Phase II Trial of Irinotecan in Children With Refractory Solid Tumors Completed NCT00004078 Phase 2 irinotecan hydrochloride
40 Phase II Study to Evaluate the Efficacy of Recombinant Interferon-Alpha in the Treatment of Recurrent Unresectable Meningiomas and Malignant Meningiomas Completed NCT00002965 Phase 2
41 Phase II Trial Of High Dose Cyclophosphamide, Cisplatin And Carmustine With Stem Cell Reconstitution Followed By Specific Cellular Therapy In Patients With Recurrent Or Refractory Brain Tumors Completed NCT00014573 Phase 2 carmustine;cisplatin;cyclophosphamide;paclitaxel
42 Combination of Hydroxyurea and Verapamil for Refractory Meningiomas Completed NCT00706810 Phase 2 Hydroxyurea;Verapamil
43 Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma Recruiting NCT03279692 Phase 2 Pembrolizumab
44 A Single Arm, Open-label, Multicenter Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma Recruiting NCT03971461 Phase 2 Lutathera
45 An Open-Label Phase II Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma Recruiting NCT02648997 Phase 2 Nivolumab - 240 mg;Ipilimumab - 3 mg/kg;Nivolumab - 480 mg;Nivolumab - 1 mg/kg
46 A Phase II, Open-label, Single Arm Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma Recruiting NCT03016091 Phase 2 Pembrolizumab
47 A Single Arm Phase II Study Of The Dual mTORC1/mTORC2 Inhibitor Vistusertib (AZD2014) Provided On An Intermittent Schedule For Sporadic Patients With Grade II-III Meningiomas That Recur Or Progress After Surgery And Radiation Recruiting NCT03071874 Phase 2 AZD2014
48 Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™: A Single-centre, Open-label, Non- Randomised, Phase I-IIa Theranostic Clinical Trial Recruiting NCT03936426 Phase 1, Phase 2 Cu-64 SARTATE and Cu-67 SARTATE
49 Effect of Hippocampal Sparing on Neurocognitive Functions and Quality of Live in Patients Irradiated in the Neurocranial Area Recruiting NCT01849484 Phase 2
50 A Phase I/II Study of Nivolumab Plus or Minus Ipilimumab in Combination With Multi-Fraction Stereotactic Radiosurgery for Recurrent High-Grade Radiation-Relapsed Meningioma Recruiting NCT03604978 Phase 1, Phase 2

Search NIH Clinical Center for Spinal Meningioma

Cochrane evidence based reviews: meningioma

Genetic Tests for Spinal Meningioma

Anatomical Context for Spinal Meningioma

MalaCards organs/tissues related to Spinal Meningioma:

41
Brain, Spinal Cord, Bone, Pituitary, Breast, Lung, Pineal

Publications for Spinal Meningioma

Articles related to Spinal Meningioma:

(show top 50) (show all 13707)
# Title Authors PMID Year
1
Bulky cardiac metastasis of intracranial solitary fibrous tumor/hemangiopericytoma: Delayed metastasis after cranial tumor resection. 38
31372191 2019
2
Letter to the Editor Regarding "Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection". 38
31426269 2019
3
Folate Receptor Overexpression in Human and Canine Meningiomas-Immunohistochemistry and Case Report of Intraoperative Molecular Imaging. 38
30113687 2019
4
One-stage frame-guided resection and reconstruction with PEEK custom-made prostheses for predominantly intraosseous meningiomas: technical notes and a case series. 38
31055698 2019
5
Petroclival Meningioma Presenting With an Ipsilateral Sixth Nerve Palsy and a Contralateral Homonymous Quadrantanopia: A Unique and Topographically Localizing Syndrome. 38
30664101 2019
6
Malignant Meningioma: An International Multicentre Retrospective Study. 38
30566646 2019
7
Geriatric brain tumor management part I: Meningioma. 38
31208835 2019
8
Ventricular Meningiomas: Surgical Strategies and a New Finding That Suggest an Origin From the Choroid Plexus Epithelium. 38
31121376 2019
9
8-Year Follow-up for Woman with Spinal Meningeal Melanocytoma in S1 Nerve Root: Case Report and Literature Review. 38
31426249 2019
10
Comparison of ABC/2 estimation and a volumetric computerized method for measurement of meningiomas using magnetic resonance imaging. 38
31401721 2019
11
Papillary meningioma: Diagnosis by intraoperative crush smear cytology. 38
31074947 2019
12
Immunological and vascular characteristics in cavernous sinus meningioma. 38
31213381 2019
13
Impact of radiotherapy in atypical meningioma recurrence: literature review. 38
29552691 2019
14
Pediatric Rhabdoid Meningioma with Extension to the Heart: A First Case Report and Literature Review. 38
31247353 2019
15
Intramedullary Thoracic Meningioma: A Rare Case Report and Review of the Literature. 38
31146040 2019
16
Survival in Patients with High-Grade Spinal Meningioma: An Analysis of the National Cancer Database. 38
31203074 2019
17
Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningioma. 38
31278690 2019
18
EQ-5D Quality-of-Life Analysis and Cost-Effectiveness After Skull Base Meningioma Resection. 38
30869135 2019
19
Presurgical differentiation between malignant haemangiopericytoma and angiomatous meningioma by a radiomics approach based on texture analysis. 38
31226327 2019
20
Cancer incidence among workers with blood lead measurements in two countries. 38
31296664 2019
21
Dural-Based Frontal Lobe Hemangioblastoma. 38
31150863 2019
22
Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma. 38
31371360 2019
23
Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging. 38
30443758 2019
24
Approach Selection and Surgical Planning in Posterior Cranial Fossa Meningiomas: How I Do It. 38
31316884 2019
25
Folate can promote the methionine-dependent reprogramming of glioblastoma cells towards pluripotency. 38
31395852 2019
26
A lateral approach to the feline cerebellar fossa: case report and identification of an external landmark for the tentorium ossium. 38
31418626 2019
27
Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects - a preliminary study. 38
31419008 2019
28
Eye Tracking for Deep Learning Segmentation Using Convolutional Neural Networks. 38
31044392 2019
29
Intradural Transpetrosectomy for Petrous Apex Meningiomas. 38
31392875 2019
30
Smoking status and perioperative adverse events in patients undergoing cranial tumor surgery. 38
31183602 2019
31
Primary central nervous system tumor treatment and survival in the United States, 2004-2015. 38
31254264 2019
32
Efficacy and safety of fractionated conformal radiation therapy in acromegaly: a long-term follow-up study. 38
31098940 2019
33
Clinical presentation and long-term outcome of primary spinal intradural malignant peripheral nerve sheath tumors. 38
31421588 2019
34
Multidisciplinary team efforts improve the surgical outcomes of sellar region lesions during pregnancy. 38
31422527 2019
35
Study Protocol for a Randomized Controlled Trial Evaluating the Efficacy of an Evidence-Based iPad-App for Cognitive Rehabilitation in Patients with Primary Brain Tumors. 38
29917115 2019
36
Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas. 38
31147831 2019
37
[Guillain-Barre syndrome complicated on post-operation with renal carcinoma and meningioma: a case report]. 38
31420639 2019
38
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. 38
31382694 2019
39
Spinal Versus Intracranial Meningioma: Aberrant Expression of CD10 and Inhibin with Relation to Clinicopathological Features and Prognosis. 38
31372897 2019
40
[Treatment of benign tumors in thoracic spinal canal by modified replanting posterior ligament complex applying piezoelectric osteotomy]. 38
31407559 2019
41
Neurofibromatosis type 2 and related disorders. 38
31425178 2019
42
Trends in phenotype in the English paediatric neurofibromatosis type 2 cohort stratified by genetic severity. 38
30993672 2019
43
Management of pediatric CNS meningiomas: CCHE-57357 experience in 39 cases. 38
31127346 2019
44
Comparison of machine learning classifiers for differentiation of grade 1 from higher gradings in meningioma: A multicenter radiomics study. 38
31425811 2019
45
Whole-tumor histogram analysis of DWI and QSI for differentiating between meningioma and schwannoma: a pilot study. 38
31396824 2019
46
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma. 38
31301014 2019
47
[Management of tumoral epilepsy in meningioma surgery: Review of the literature and survey of French national practices]. 38
31100348 2019
48
Subjective cognitive functioning in patients with a meningioma: Its course and association with objective cognitive functioning and psychological symptoms. 38
31141624 2019
49
Large dural-based mass with bony hyperostosis in a 16-year-old male: IgG4-related disease mimicking lymphoplasmacyte-rich meningioma. 38
31073682 2019
50
Challenging the concept that late recurrence and death from tumor are common after fractionated radiotherapy for benign meningioma. 38
31071515 2019

Variations for Spinal Meningioma

Expression for Spinal Meningioma

Search GEO for disease gene expression data for Spinal Meningioma.

Pathways for Spinal Meningioma

GO Terms for Spinal Meningioma

Sources for Spinal Meningioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....